Crossmark

Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma

Published Online: 2021-01-20

Published Print: 2021-08

Authors

Im, Jung Ho

Choi, Gi Hong

Lee, Woo Jung

Han, Dai Hoon

Park, Seung Woo

Bang, Seungmin

Choi, Hye Jin

Seong, Jinsil https://orcid.org/0000-0003-1794-5951
License Information

Text and Data Mining valid from 2021-01-20

Version of Record valid from 2021-01-20
More Information

Article History

Received: 26 September 2020

Accepted: 10 January 2021

First Online: 20 January 2021

Compliance with ethical standards

:

: The authors declare that there are no conflict of interests.

Document is current